Cancer Drug Stocks Run Wild Following Puma Biotechnology Ph-3 Trial (PBYI) (ONTY) (DARA) (ARRY) (GALE)
Tweet Send to a Friend
Puma Biotechnology, Inc. (NYSE: PBYI) stock surged 200% after the close yesterday when ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
